What Researchers Did
Researchers conducted a randomized controlled double-blind trial to compare hyperbaric oxygen with normobaric oxygen for neurological sequelae in patients with carbon monoxide poisoning.
What They Found
The study found that more patients in the hyperbaric oxygen group required additional treatments (28% vs 15%, P = 0.01 for all patients). Furthermore, hyperbaric oxygen patients showed a worse outcome in the learning test at treatment completion (P = 0.01 for all patients).
What This Means for Canadian Patients
Canadian patients experiencing carbon monoxide poisoning may not benefit more from hyperbaric oxygen than from normobaric oxygen, and it could potentially lead to more required treatments. This suggests that current treatment protocols should be carefully considered regarding the use of hyperbaric oxygen.
Canadian Relevance
This study was conducted in Australia and has no direct Canadian connection.
Study Limitations
A limitation of this study is its single-center design, which may affect the generalizability of the findings.